Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thomas D. Carey Insider Profile
4 Followers
Thomas D. Carey, Director at Exact Sciences, holds 5.29K shares in Exact Sciences (Ticker: EXAS), holds ― shares in SomaLogic (Ticker: SLGC), holds 79.41K shares in Standard BioTools (Ticker: LAB).
Thomas D. Carey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Thomas D. Carey holds in companies
Most Profitable Insider Trade
The most profitable trade made by Thomas D. Carey
Thomas D. Carey's Trading History
Exact Sciences
Jun 03, 2021
Director
Uninformative Sell
1.84M
$294.18K
SomaLogic
―
―
―
―
Standard BioTools
Jan 09, 2024
Director
Uninformative Buy
―
$196.94K
List of latest transactions for each holding click on a transaction to see Thomas D. Carey's performance on stock
You May Also Like
Thomas D. Carey insider profile FAQ
What is the percentage of profitable transactions made by Thomas D. Carey?
The percentage of profitable transactions made by Thomas D. Carey is ―.
What is the average return per transaction made by Thomas D. Carey?
The average return per transaction made by Thomas D. Carey is ―.
What stocks does Thomas D. Carey hold?
Thomas D. Carey holds: EXAS, SLGC, LAB stocks.
What was Thomas D. Carey’s latest transaction?
Thomas D. Carey latest transaction was an Uninformative Sell of $1.84M.
What was Thomas D. Carey's most profitable transaction?
Thomas D. Carey’s most profitable transaction was an Informative Buy of EXAS stock on August 18, 2017. The return on the trade was 28.90%.
What is Thomas D. Carey's role in Exact Sciences?
Thomas D. Carey's role in Exact Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.